TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose Study of the Efficacy, Safety, Tolerability, and Pharmacodynamics of Subcutaneously-Administered REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Brief Summary: The primary objective was to assess the clinical efficacy of repeated subcutaneous (SC) doses of Dupilumab in adult participants with moderate-to-severe atopic dermatitis (AD).


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Tralokinumab Dose 1; Type: EXPERIMENTAL; Interventions: Biological: Tralokinumab Dose 1 | Arm Label: Tralokinumab Dose 2; Type: EXPERIMENTAL; Interventions: Biological: Tralokinumab Dose 2 | Arm Label: Tralokinumab Dose 3; Type: EXPERIMENTAL; Interventions: Biological: Tralokinumab Dose 3 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: Tralokinumab Dose 1; Assigned to Arm(s): Tralokinumab Dose 1 | Intervention Type: BIOLOGICAL; Name: Tralokinumab Dose 2; Assigned to Arm(s): Tralokinumab Dose 2 | Intervention Type: BIOLOGICAL; Name: Tralokinumab Dose 3; Assigned to Arm(s): Tralokinumab Dose 3
B: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Other: Background treatment | Arm Label: Dupilumab 150 mg; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Other: Background treatment | Arm Label: Dupilumab 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Other: Background treatment | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 150 mg, Dupilumab 300 mg | Intervention Type: OTHER; Name: Background treatment; Assigned to Arm(s): Dupilumab 150 mg, Dupilumab 300 mg, Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Dupilumab 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 300 mg
D: Arm Label: MEDI9929 280 mg; Type: EXPERIMENTAL; Interventions: Biological: MEDI9929 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI9929; Assigned to Arm(s): MEDI9929 280 mg | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya
Brief Summary: This pilot study aims to determine whether an agricultural intervention will improve food security, prevent treatment failure, reduce co-morbidities, and decrease secondary HIV transmission risk among people living with HIV/AIDS. The intervention will include: a) a human-powered water pump and other required farm commodities, b) a micro-finance loan (\~$75) to purchase the pump and agricultural implements, and c) education in sustainable farming practices.


Options:
A: Arm Label: Multi-sectoral agricultural intervention; Type: EXPERIMENTAL; Interventions: Other: Multi-sectoral agricultural intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Multi-sectoral agricultural intervention; Assigned to Arm(s): Multi-sectoral agricultural intervention
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Cash; Type: EXPERIMENTAL; Interventions: Other: Cash | Arm Label: Voucher; Type: EXPERIMENTAL; Interventions: Other: Voucher | Arm Label: Food; Type: EXPERIMENTAL; Interventions: Other: Food | Intervention Type: OTHER; Name: Cash; Assigned to Arm(s): Cash | Intervention Type: OTHER; Name: Voucher; Assigned to Arm(s): Voucher | Intervention Type: OTHER; Name: Food; Assigned to Arm(s): Food
C: Arm Label: Classic Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Classic Intervention | Arm Label: Minimum Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Minimum Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Classic Intervention; Assigned to Arm(s): Classic Intervention | Intervention Type: BEHAVIORAL; Name: Minimum Intervention; Assigned to Arm(s): Minimum Intervention
D: Arm Label: Outpatient therapeutic program, counseling and cash transfer; Type: EXPERIMENTAL; Interventions: Other: Outpatient therapeutic program, counseling and cash transfer | Arm Label: Outpatient therapeutic program and counseling; Type: ACTIVE_COMPARATOR; Interventions: Other: Outpatient therapeutic program and counseling | Intervention Type: OTHER; Name: Outpatient therapeutic program, counseling and cash transfer; Assigned to Arm(s): Outpatient therapeutic program, counseling and cash transfer | Intervention Type: OTHER; Name: Outpatient therapeutic program and counseling; Assigned to Arm(s): Outpatient therapeutic program and counseling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya
Brief Summary: This pilot study aims to determine whether an agricultural intervention will improve food security, prevent treatment failure, reduce co-morbidities, and decrease secondary HIV transmission risk among people living with HIV/AIDS. The intervention will include: a) a human-powered water pump and other required farm commodities, b) a micro-finance loan (\~$75) to purchase the pump and agricultural implements, and c) education in sustainable farming practices.


Options:
A: Arm Label: Cash transfer; Type: EXPERIMENTAL; Interventions: Other: Cash transfer | Arm Label: Comparison group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cash transfer; Assigned to Arm(s): Cash transfer
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Cash; Type: EXPERIMENTAL; Interventions: Other: Cash | Arm Label: Voucher; Type: EXPERIMENTAL; Interventions: Other: Voucher | Arm Label: Food; Type: EXPERIMENTAL; Interventions: Other: Food | Intervention Type: OTHER; Name: Cash; Assigned to Arm(s): Cash | Intervention Type: OTHER; Name: Voucher; Assigned to Arm(s): Voucher | Intervention Type: OTHER; Name: Food; Assigned to Arm(s): Food
C: Arm Label: Classic Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Classic Intervention | Arm Label: Minimum Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Minimum Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Classic Intervention; Assigned to Arm(s): Classic Intervention | Intervention Type: BEHAVIORAL; Name: Minimum Intervention; Assigned to Arm(s): Minimum Intervention
D: Arm Label: Multi-sectoral agricultural intervention; Type: EXPERIMENTAL; Interventions: Other: Multi-sectoral agricultural intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Multi-sectoral agricultural intervention; Assigned to Arm(s): Multi-sectoral agricultural intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya
Brief Summary: This pilot study aims to determine whether an agricultural intervention will improve food security, prevent treatment failure, reduce co-morbidities, and decrease secondary HIV transmission risk among people living with HIV/AIDS. The intervention will include: a) a human-powered water pump and other required farm commodities, b) a micro-finance loan (\~$75) to purchase the pump and agricultural implements, and c) education in sustainable farming practices.


Options:
A: Arm Label: Comparison Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active Intervention 1; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm 1 | Arm Label: Active Intervention 2; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm 2 | Intervention Type: BEHAVIORAL; Name: Active Arm 1; Assigned to Arm(s): Active Intervention 1 | Intervention Type: BEHAVIORAL; Name: Active Arm 2; Assigned to Arm(s): Active Intervention 2
B: Arm Label: Cash transfer; Type: EXPERIMENTAL; Interventions: Other: Cash transfer | Arm Label: Comparison group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cash transfer; Assigned to Arm(s): Cash transfer
C: Arm Label: No incentive; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: KES financial incentive 1; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Arm Label: KES financial incentive 2; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Arm Label: KES financial incentive 3; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Arm Label: KES financial incentive 4; Type: EXPERIMENTAL; Interventions: Behavioral: Financial incentive | Intervention Type: BEHAVIORAL; Name: Financial incentive; Assigned to Arm(s): KES financial incentive 1, KES financial incentive 2, KES financial incentive 3, KES financial incentive 4
D: Arm Label: Multi-sectoral agricultural intervention; Type: EXPERIMENTAL; Interventions: Other: Multi-sectoral agricultural intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Multi-sectoral agricultural intervention; Assigned to Arm(s): Multi-sectoral agricultural intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Utilization of Nintendo Wii™ in Outpatient Rehabilitation Following Total Knee Replacement
Brief Summary: The purpose of this study is to identify whether the utilization of the Nintendo Wii™ gaming system, as an adjunct to conventional outpatient rehabilitation therapy, influence outcomes of patients following total knee replacement (TKR). The investigators hypothesize that the Nintendo Wii™ gaming system has a positive influence in the outcomes of patients following TKR.


Options:
A: Arm Label: Hand Mentor Therapy; Type: EXPERIMENTAL; Interventions: Device: Hand Mentor (TM) robotic stroke therapy device | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Device: Home Therapy Program | Intervention Type: DEVICE; Name: Hand Mentor (TM) robotic stroke therapy device; Assigned to Arm(s): Hand Mentor Therapy | Intervention Type: DEVICE; Name: Home Therapy Program; Assigned to Arm(s): Control
B: Arm Label: Nintendo Wii FitTM; Type: EXPERIMENTAL; Interventions: Other: Wii Fit | Arm Label: Lower extremity exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Lower Extremity Exercise | Intervention Type: OTHER; Name: Wii Fit; Assigned to Arm(s): Nintendo Wii FitTM | Intervention Type: OTHER; Name: Lower Extremity Exercise; Assigned to Arm(s): Lower extremity exercise
C: Arm Label: VRT; Type: EXPERIMENTAL; Interventions: Other: virtual reality training | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: control | Intervention Type: OTHER; Name: virtual reality training; Assigned to Arm(s): VRT | Intervention Type: OTHER; Name: control; Assigned to Arm(s): control
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: LapSimGyn training until expert proficiency level is reached | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional clinical education | Intervention Type: BEHAVIORAL; Name: LapSimGyn training until expert proficiency level is reached; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Traditional clinical education; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Placebo-controlled, Randomized, Parallel-group Study of the Safety and Effects of YisuiShengxueGranules on Thalassemia Presenting the Syndrome of Deficiency of Liver/Kidney-yin, and Asthenia of Essence/Blood.
Brief Summary: The primary objectives of this study are to evaluate whether Yisui Shengxue Granules therapy can increase the hemoglobin level in peripheral blood and alleviate the symptoms, and at the same time, evaluate its safety in the treatment of Thalassemia with the syndrome of deficiency of liver-yin and kidney-yin, and asthenia of essence and blood.


Options:
A: Arm Label: research; Type: N/A; Interventions: Drug: Yisuishengxue Granule | Arm Label: clinical research; Type: N/A; Interventions: Drug: Yisuishengxue Granule | Intervention Type: DRUG; Name: Yisuishengxue Granule; Assigned to Arm(s): clinical research, research
B: Arm Label: thalidomide thalassemia; Type: EXPERIMENTAL; Interventions: Drug: Thalidomide | Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): thalidomide thalassemia
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Drug: Colla corii asini | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Colla corii asini; Assigned to Arm(s): Intervention group
D: Arm Label: thalidomide thalassemia; Type: EXPERIMENTAL; Interventions: Drug: Thalidomide | Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): thalidomide thalassemia

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Gum Chewing After Gynecologic Laparoscopy Stimulate Earlier Return of Bowel Motility?
Brief Summary: Gum chewing has been reported to stimulate bowel motility after open surgery, such as cesarean section and other abdominal surgeries. In general, after laparoscopic surgery problems with reduced bowel motility are not as common as after open surgery. In this study the investigators test the hypothesis that gum chewing is enhancing rapid return of bowel motility after gynecologic laparoscopic surgery. Further the investigators study patient satisfaction and potential side effects of postoperative gum chewing.


Options:
A: Arm Label: 1.; Type: ACTIVE_COMPARATOR; Interventions: Other: Trident sugarless chewing gum. | Arm Label: 2.; Type: PLACEBO_COMPARATOR; Interventions: Other: One control group (these do not chew gum). | Intervention Type: OTHER; Name: Trident sugarless chewing gum.; Assigned to Arm(s): 1. | Intervention Type: OTHER; Name: One control group (these do not chew gum).; Assigned to Arm(s): 2.
B: Arm Label: chewing gum; Type: EXPERIMENTAL; Interventions: Behavioral: gum chewing | Intervention Type: BEHAVIORAL; Name: gum chewing; Assigned to Arm(s): chewing gum
C: Arm Label: major surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: minor surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: ileostomy and colostomy; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: other surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil and chewing gum; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: chewing gum; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: water; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery
D: Arm Label: Treatment arm: coffee; Type: ACTIVE_COMPARATOR; Interventions: Other: Postoperative coffee | Arm Label: Water arm; Type: PLACEBO_COMPARATOR; Interventions: Other: water | Intervention Type: OTHER; Name: Postoperative coffee; Assigned to Arm(s): Treatment arm: coffee | Intervention Type: OTHER; Name: water; Assigned to Arm(s): Water arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Polyp Detection With The Peerscope System™: A Randomized Tandem Colonoscopy Study
Brief Summary: The PeerScope System consists of Peer Medical camera heads, endoscopes, video system, light source and other ancillary equipment. The system is intended for endoscopic diagnosis, treatment and video observation of the digestive tract. The PeerScope system model B is indicated for use for endoscopy and endoscopic treatment within the lower digestive tract (including the anus, rectum, sigmoid colon, colon and ileocecal valve) of adults patients.

Objective:To compare the additional diagnostic yield obtained by using the PeerScope System™ extended view vs. the diagnostic yield obtained by the Standard view colonoscopy.

In addition, time measurements including time to cecum, time for withdrawal and overall procedure time will be analyzed and reported for each group.


Options:
A: Arm Label: Group A (study group); Type: ACTIVE_COMPARATOR; Interventions: Device: Colonoscopy done with:PeerMedical System and Olympus/Pentax/Fuji colonoscopy system | Arm Label: Group B (control group); Type: ACTIVE_COMPARATOR; Interventions: Device: Colonoscopy done with:PeerMedical System and Olympus/Pentax/Fuji colonoscopy system | Intervention Type: DEVICE; Name: Colonoscopy done with:PeerMedical System and Olympus/Pentax/Fuji colonoscopy system; Assigned to Arm(s): Group A (study group), Group B (control group)
B: Intervention Type: PROCEDURE; Name: Colonoscopy; Assigned to Arm(s): N/A
C: Arm Label: Group A - COLO, then TER; Type: EXPERIMENTAL; Interventions: Device: Third Eye Retroscope | Arm Label: Group B - TER, then COLO; Type: ACTIVE_COMPARATOR; Interventions: Device: Third Eye Retroscope | Intervention Type: DEVICE; Name: Third Eye Retroscope; Assigned to Arm(s): Group A - COLO, then TER, Group B - TER, then COLO
D: Intervention Type: DRUG; Name: Esomeprazole; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Adductor-Canal-Blockade on High Pain Responders the 1. or 2. Postoperative Day After Total Knee Arthroplasty
Brief Summary: The purpose of this study is to determine whether Adductor-Canal-Blockade (ACB) is superior to placebo when it comes to analgetic efficacy in high pain responders after Total Knee Arthroplasty (TKA). High pain responders are defined as patients reporting VAS \> 60 during knee flexion the 1. or 2. day after surgery.


Options:
A: Arm Label: Arm RP; Type: OTHER; Interventions: Drug: Ropivacaine, Drug: Saline | Arm Label: Arm PR; Type: OTHER; Interventions: Drug: Ropivacaine, Drug: Saline | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Arm PR, Arm RP | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Arm PR, Arm RP
B: Arm Label: Adductor-Canal-Block, Ropivacain; Type: EXPERIMENTAL; Interventions: Procedure: Ropivacain | Arm Label: Adductor Canal Block, Placebo (saline); Type: PLACEBO_COMPARATOR; Interventions: Procedure: Saline | Intervention Type: PROCEDURE; Name: Ropivacain; Assigned to Arm(s): Adductor-Canal-Block, Ropivacain | Intervention Type: PROCEDURE; Name: Saline; Assigned to Arm(s): Adductor Canal Block, Placebo (saline)
C: Arm Label: Adductor-Canal-Blockade; Type: EXPERIMENTAL; Interventions: Procedure: Adductor-Canal-Blockade | Arm Label: Adductor-Canal-blockade with saline; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Adductor-Canal-blockade with saline | Intervention Type: PROCEDURE; Name: Adductor-Canal-Blockade; Assigned to Arm(s): Adductor-Canal-Blockade | Intervention Type: PROCEDURE; Name: Adductor-Canal-blockade with saline; Assigned to Arm(s): Adductor-Canal-blockade with saline
D: Arm Label: Adductor-Canal-Blockade; Type: EXPERIMENTAL; Interventions: Procedure: Adductor-Canal-Blockade | Arm Label: Femoral Nerve Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Femoral Nerve Block | Intervention Type: PROCEDURE; Name: Adductor-Canal-Blockade; Assigned to Arm(s): Adductor-Canal-Blockade | Intervention Type: PROCEDURE; Name: Femoral Nerve Block; Assigned to Arm(s): Femoral Nerve Block

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of a Mixture of Inulin and Fructo-oligosaccharide on Lactobacillus and Bifidobacterium Intestinal Microbiota of Patients Receiving Radiotherapy: a Randomised, Double-blind, Placebo-controlled Trial.
Brief Summary: Abdominal and pelvic radiotherapy (RT) reduces the renewal capacity of the epithelium. Rectal biopsies obtained from patients receiving pelvic RT have revealed atrophy of surface epithelium, acute cryptitis, crypt abscesses, crypt distortion and atrophy, and stromal inflammation. Modifications in intestinal microbiota, such as an increase in the number of pathogens, may contribute to intestinal injury. The prebiotic effect of a carbohydrate is assessed by its capacity to stimulate the proliferation of healthy bacteria (Bifidobacterium, Lactobacillus) rather than pathogenic bacteria (Clostridium, E. coli).

The hypothesis of the study is that a mixture of inulin and fructooligosaccharide could modulate Lactobacillus and Bifidobacterium and reduce the intestinal injury in patients affected of gynaecological cancer and treated with abdominal radiotherapy.


Options:
A: Arm Label: Fiber supplement; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Inulin and Fructo-oligosaccharide | Arm Label: Maltodextrine; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Maltodextrine | Intervention Type: DIETARY_SUPPLEMENT; Name: Inulin and Fructo-oligosaccharide; Assigned to Arm(s): Fiber supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Maltodextrine; Assigned to Arm(s): Maltodextrine
B: Arm Label: protons; Type: EXPERIMENTAL; Interventions: Procedure: radiation | Arm Label: carbon ions; Type: EXPERIMENTAL; Interventions: Procedure: radiation | Intervention Type: PROCEDURE; Name: radiation; Assigned to Arm(s): carbon ions, protons
C: Arm Label: Arm Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Arm Soy Supplement; Type: EXPERIMENTAL; Interventions: Drug: Soy Supplement | Intervention Type: DRUG; Name: Soy Supplement; Assigned to Arm(s): Arm Soy Supplement | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm Placebo
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Drug: Interferon, Retinoic Acid and radiation | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cisplatin and radiation | Intervention Type: DRUG; Name: Interferon, Retinoic Acid and radiation; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Cisplatin and radiation; Assigned to Arm(s): Group B

Answer: A